Pancreatic Cancer Research

ResearcherSamsung Medical CenterActive in the last 2 years

Hee Chul Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0385-9681; OpenAlex author ID A5056642475. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. Co-author DOI 10.1002/jcsm.13643↗
  2. Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy. First author DOI 10.1016/j.ctro.2024.100732↗
  3. The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. Co-author DOI 10.3390/cancers14194556↗
  4. Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy. Co-author DOI 10.1177/0300891620937795↗
  5. Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients? Co-author DOI 10.5009/gnl16014↗
  6. Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review. Co-author DOI 10.1097/coc.0b013e31821a83d7↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jeong Il Yu · 4 shared papers, 2021–2025 · strength 0.68
  2. Jong Kyun Lee · 4 shared papers, 2012–2025 · strength 0.54
  3. Kyu Taek Lee · 4 shared papers, 2012–2025 · strength 0.54
  4. Joon Oh Park · 4 shared papers, 2012–2025 · strength 0.54
  5. Jin Seok Heo · 3 shared papers, 2022–2025 · strength 0.52
  6. In Woong Han · 3 shared papers, 2022–2025 · strength 0.52
  7. Sang Hyun Shin · 3 shared papers, 2022–2025 · strength 0.52
  8. Joo Kyung Park · 3 shared papers, 2022–2025 · strength 0.52
  9. Kangpyo Kim · 2 shared papers, 2024–2025 · strength 0.38
  10. Ji Hye Min · 2 shared papers, 2024–2025 · strength 0.38
  11. Jung Yong Hong · 2 shared papers, 2024–2025 · strength 0.38
  12. Sook‐Young Woo · 1 shared paper, 2025 · strength 0.20
  13. Hongbeom Kim · 1 shared paper, 2025 · strength 0.20
  14. Jin Ho Choi MD · 1 shared paper, 2025 · strength 0.20
  15. Kyunga Kim · 1 shared paper, 2024 · strength 0.18
  16. Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.18
  17. Tae Hyun Kim · 1 shared paper, 2021 · strength 0.16
  18. Won Kyung Cho · 1 shared paper, 2021 · strength 0.16
  19. Eui Kyu Chie · 1 shared paper, 2021 · strength 0.16
  20. Hyunju Shin · 1 shared paper, 2022 · strength 0.14
  21. Seung Tae Kim · 1 shared paper, 2012 · strength 0.03
  22. Kee‐Taek Jang · 1 shared paper, 2012 · strength 0.03
  23. Young Suk Park · 1 shared paper, 2012 · strength 0.03
  24. Ho Yeong Lim · 1 shared paper, 2012 · strength 0.03
  25. Seong Ho Choi · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.